BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,201 | -31.4% | 50,000 | -9.1% | 0.00% | -25.0% |
| Q2 2023 | $1,750 | +5.5% | 55,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,658 | -4.8% | 55,000 | +22.2% | 0.00% | -20.0% |
| Q4 2022 | $1,742 | -99.9% | 45,000 | +80.0% | 0.01% | +25.0% |
| Q3 2022 | $1,200,000 | +112.0% | 25,000 | +78.6% | 0.00% | +100.0% |
| Q2 2022 | $566,000 | -39.7% | 14,000 | -11.4% | 0.00% | 0.0% |
| Q1 2022 | $939,000 | -24.3% | 15,800 | +0.6% | 0.00% | -33.3% |
| Q4 2021 | $1,241,000 | -7.0% | 15,700 | +2.6% | 0.00% | -25.0% |
| Q3 2021 | $1,334,000 | +127.3% | 15,300 | +188.7% | 0.00% | +100.0% |
| Q2 2021 | $587,000 | -63.6% | 5,300 | -75.1% | 0.00% | -60.0% |
| Q1 2021 | $1,613,000 | -9.0% | 21,300 | +6.5% | 0.01% | -28.6% |
| Q4 2020 | $1,773,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |